baber/WOPTO huggingface dataset:
Patent NZ-500941-A (NZ)
Title: Fungicidal mixtures comprising a phenyl benzyl ether derivative and a N-acetonylbenzamide
Inventor: BIRNER ERICH
IPC: A01N47/24
Filed: 1998-05-13
Abstract: A fungicidal mixture comprising: i) a phenyl benzyl ether derivative of formula I.a, I.b or I.c, and/or a carbamate of formula Id, wherein: X is CH or N, n is 0, 1 or 2 and R is halogen, alkyl or haloalkyl, it being possible for the radicals R to be different if n is 2, or a salt or adduct thereof; AND ii) a N-acetonylbenzamide of formula II R1 and R3 are independently halogen or alkyl; R2 is cyano, alkyl, alkenyl, alkynyl or alkoxy; R4 is hydrogen or alkyl; R5 is alkyl; R6 is thiocyano, isothiocyano or halogen; or a salt or adduct thereof. in a synergistically effective amount. Also described is a method for controlling harmful fungi, which comprises treating the harmful fungi, their habitat, or the plants, seeds, soils, areas, materials or spaces to be kept free of them with synergistically effective amounts of a compound of the formula I and a compound of the formula II or a salt or adduct thereof.
Patent NZ-502096-A (NZ)
Title: Providing services to users of PSTN, service resources locatable from SCP using URIs
Inventor: PENKLER DAVID
IPC: H04L29/12
Filed: 1996-12-11
Abstract: Services are provided to users of a public switched telecommunications network (PSTN) that includes a service control subsystem (SCP) by provisioning a server 51 with service resource items that are each associated with a predetermined code.  When the SCP receives a service request, a service logic program is run, and the server 51 is accessed to utilise the service resource item corresponding to the request.  The service resource items are located using Universal Resource Indicators (URIs).  Predetermined code contained in the service request is translated into the URI associated with the service resource, and the URI is used to access the service resource item.
Patent NZ-506002-A (NZ)
Title: Encryption processing for streaming media by assigning tag value, creating packet key, encrypting data and adding tag value
Inventor: RAIKE WILLIAM MICHAEL
IPC: H04L9/30
Filed: 2000-07-26
Abstract: An encrypted random base key is transmitted as an open key to the recipient. Each packet of data is encrypted by assigning a tag value to each packet, creating a packet key by computing a secure hash of the base key and the tag value of the packet, encrypting the packet data using the packet key adding the tag value to the corresponding encrypted packet data and inserting the processed packet into the packet stream. The stream is the then transmitted to the recipient. Each packet is decrypted by extracting the tag value from each packet, recreating the packet key by computing a secure hash of the base key and the packet's tag value, decrypting the packet data using the packet key, and storing or outputting the decrypted packet data in a form suitable for playing the streamed media.
Patent NZ-506135-A (NZ)
Title: Monocyte colony inhibitory factor (M-CIF) derivatives and their use in treating sepsis
Inventor: GENTZ REINER L
IPC: A61P43/00
Filed: 1997-09-30
Abstract: An isolated polypeptide that is a Monocyte Colony Inhibitory Factor (MCIF) N-terminal deletion mutant, vectors containing the polypeptide, production of the polypeptide and its use in the manufacture of medicaments.
Patent NZ-507550-A (NZ)
Title: Cover for earth electrode being removable cap to fit into tube
Inventor: CRILLY STEPHEN ARTHUR
IPC: H01R4/66
Filed: 2000-10-17
Abstract: An earth electrode cover designed as a cap to fit into a tube is disclosed, with the cap being removable for testing purposes.
Patent NZ-510565-A (NZ)
Title: Building material compositions prepared from a particulate polysaccharide or derivative thereof
Inventor: KIESEWETTER RENE
IPC: C09D7/12
Filed: 2001-03-15
Abstract: A building material composition is prepared from or has added to it a particulate material consisting of a particulate polysaccharide or a particulate polysaccharide derivative.  The particulate material is prepared by: a) forming a feed composition consisting of at least one water swellable or water soluble polysaccharide or a derivative thereof and 35-99wt% of water; b) contacting the feed composition with a gas stream in a mill thereby converting simultaneously the water of the feed composition into water vapour and the water swellable or water-soluble polysaccharide or a derivative thereof into a solid state form of finely particulate material; c) separating the particulate material from the gas stream and d) optionally drying the particulate material.
Patent NZ-512275-A (NZ)
Title: Probiotic therapy delivered to women by oral administration of selected lactobascilli that have antagonistic properties against urogenital pathogens
Inventor: REID GREGOR
IPC: C12Q1/68
Filed: 1999-12-10
Abstract: Described are formulations for the prevention of infection and/or abnormal conditions of mucosae and/or skin caused by any pathogen and/or any disease, and more particularly for the prevention of sexually transmitted infections, HIV and HSV in particular, and herpetic lesions. The formulations could be used as a prophylactic agent to prevent accidental infection of health care workers. They could be used also for the healing and/or treatment of burn wounds and prevention of further infection. Also described is the development of a unique vaginal/ano-rectal applicator for the uniform delivery of any topical formulations to treat and/or prevent any infection and/or abnormal conditions of mucosa cavity caused by any pathogen and/or disease.
Patent NZ-514833-A (NZ)
Title: Strecher Suspension Linkages
Inventor: HENDERSON ROBERT JAMES
IPC: B60P1/00
Filed: 2001-10-16
Abstract: A stretcher suspension device for a vehicle is disclosed. The suspension device comprises a mounting base, a stretcher receiving member and a linkage including spring means. The linkage has link members arranged to permit the stretcher receiving members to move relative to the mounting base. The mounting base being arranged to be engageable at least in part about a wheel arch protrusion in a floor of the vehicle with which floor the mounting base is mountable.
Patent NZ-519345-A (NZ)
Title: Composite closure cap
Inventor: BOURREAU JEAN-MARIE
IPC: B65D51/24
Filed: 2000-12-11
Abstract: The invention concerns a cap (1) comprising as assembly consisting of: a) a plastic insert (2) comprising a head (3) with closure means (31, 32) and a threaded skirt (4), and b) a metal wall. The invention is characterised in that: 1) said metal wall (5) covers all or part of the outer surface of said insert (2) and includes at least a metal skirt (51) for receiving said skirt (4) of said insert (2); said metal skirt (51) includes an edge (510) crimped to said insert (2) so as to assemble together said metal wall (5) and said insert (2); 3) said cap comprises means designed to provide weight and/or volume to the part of said cap located above said sealing closure means (31, 32).
Patent NZ-520823-A (NZ)
Title: Anxiety method
Inventor: MAYOL ROBERT F
IPC: A61K31/506
Filed: 2000-10-18
Abstract: The use of 6-hydroxy-8-[4-[4-(2-pyrimidinyl)-piperazinyl]-butyl]-8-azaspiro[4,5]-7,9dione for ameliorating an anxiety state in a mammal.
Patent NZ-522337-A (NZ)
Title: Production of TcR gamma delta T cells
Inventor: BELL DAVID N
IPC: A61K35/12
Filed: 2001-04-03
Abstract: A method for expanding T cell receptor gamma delta (TcRãä+) T cells in a sample comprising: (1) culturing cells in the starting sample in a first culture medium comprising a T cell mitogen, a growth factor having interleukin-2-like activity and a growth factor having interleukin-7-like activity; and (2) culturing the cells obtained in step (1) in a second culture medium comprising a growth factor having interleukin-2-like activity and a growth factor having interleukin-7-like activity to expand TcRãä+ T cells.
Patent NZ-522494-A (NZ)
Title: Pneumatic press machine door where door is arched to fit with the cyclindrical press
Inventor: FOUILLET JACQUES
IPC: B30B9/26
Filed: 2002-11-08
Abstract: A  door  device (1) for a tank (2), provided  with  at least  one  loading  and unloading aperture,  the  door  (4) having  a  generally arched form substantially  fitting  the curve  of  the wall of the tank (2), characterized  in  that said  door (4) substantially consists of a structural casing (5)  in  the  form  of  a metal plate provided  with  folded lateral  edges (5') and of a filling body (6), also  in  the form  of  a plate, mounted in the casing (5), said body  (6) being  held  in  said casing (5) by the  folded  edges  (5') thereof,  due to the arching experienced by the casing  body assembly and the resultant arched overlapping arrangement.
Patent NZ-523497-A (NZ)
Title: Antifungal and/or anitbacterial peptides, preparation methods and composition containing same
Inventor: DIMARQ JEAN-LUC
IPC: A01N63/50
Filed: 2001-07-05
Abstract: Peptides derived from heliomicine by substitution of one or several amino acids are described. They are characterised in that the peptides correspond to formula (I) wherein: X1, X17, X21 X43 are amino acids; X16, X44 are small polar amino acids; X19 is a large polar amino acid; X36 is a small or lightly hydrophobic amino acid; X38 is a lightly hydrophobic or small amino acid. The substitutions being such that: at least one of X1, X17, X21and X43 is a basic or polar, advantageously large polar amino acid, and/or at least one of the amino acids X16, X44 is a basic amino acid or a large polar amino acid, and/or X19 is a basic amino acid, and/or at least one of the amino acids X36, X38 is a strongly hydrophobic amino acid. Also described are anti-fungal and/or antibacterial compositions comprising at least one of the aforementioned peptides.
Patent NZ-533727-A (NZ)
Title: Anti-Alpha v Beta 3 recombinant human antibodies, nucleic acids encoding same and methods of use
Inventor: HUSE WILLIAM D
IPC: A61P21/00
Filed: 2000-06-23
Abstract: Integrins are a class of cell adhesion receptors that mediate both cell-cell and cell-extracellular matrix adhesion events. The vitronectin binding integrins consist of at least three different alpha v containing integrins, one being alpha v beta 3. Disclosed is an antibody or functional fragment comprising at least one CDR with one or more amino acid substitutions compared to LM609, and exhibiting enhanced binding activity to alpha v beta 3 compared to LM609. (62) (62) Divided out of 523291
Patent NZ-535286-A (NZ)
Title: Matrix for sustained, invariant and independent release of active compounds
Inventor: BROGMANN BIANCA
IPC: A61K9/22
Filed: 2003-04-04
Abstract: Disclosed is a storage stable pharmaceutical formulation comprising preferably two active compounds in a non-swellable diffusion matrix, whereby the compounds are released from the matrix in a sustained, invariant and, if several compounds are present, independent manner and the matrix is determined with respect to its substantial release characteristics by ethylcellulose and at least one fatty alcohol. Also disclosed are methods for producing such pharmaceutical formulations.
Patent NZ-536667-A (NZ)
Title: Data analysis and display of complex medical information for ICU personel
Inventor: MERRETT PHILIP JONATHAN
IPC: G06F19/00
Filed: 2003-05-21
Abstract: A system and method for the gathering, analysis and display of information in data intensive time varying environments, in particular for data analysis in a critical care environment, provides a graphical display of derived information comprising a series of bar charts (a - h) representative of a corresponding series of functions 32. Each bar chart comprises a linear series of time-divided segments 34 wherein each segment 34 of each bar chart (a - h) is assigned a colour corresponding to the status of that function 32. The status of each function 32 is derived by scoring contributory data indicators in accordance with pre-set threshold values, and logically combining to produce a status score for each function. Interventions that affect particular functions may also be recorded and displayed against those functions so that their effect is readily discernible. In this way the status of several health indication parameters can be readily displayed to the clinician along with the times of intervention.
Patent NZ-536923-A (NZ)
Title: Mould guard for loading mouldable material into a machine with a pair of rollers.
Inventor: WILLETT PAUL EATON
IPC: A21C7/01
Filed: 2004-12-01
Abstract: A moulding machine for shaping bread dough that has loading means for safely loading dough into the machine is disclosed. Dough is loaded into conduit feeders (e),(f) mounted on a turntable 11. The turntable 11 allows each conduit to be interchangeably located above the inlet to the sheeting rollers (a). The larger conduit (e) has an elbow bend to prevent operator access to the rollers, while the smaller conduit is sized so that the operator would be unable to insert their arm.
Patent NZ-537119-A (NZ)
Title: An ion generating device
Inventor: SANTHOUSE DANIEL
IPC: A45D2/00
Filed: 2003-05-29
Abstract: There is provided a device for hair care having a housing with at least one aperture, one or more ion generators for selectively generating concentrations of ions having different combinations of intensity and polarity, and one or more ion emitters for selectively emitting concentrations of ions having different combinations of intensity and polarity. The device can be any device or combination of such devices, suitable for use with hair and for to optimize the known beneficial effects of ionization to hair of the user.
Patent NZ-540495-A (NZ)
Title: 1,3-Dihydro-imidazole fused-ring compound
Inventor: KIRA KAZUNOBU
IPC: A61P9/00
Filed: 2003-12-02
Abstract: Disclosed is a compound represented by the general formula (I), or a salt or a hydrate thereof wherein: T1 stands for a piperazin-1-yl group, a 3-amino-piperidin-1-yl group or a 3-methylamino-piperidin-1-yl group; X3 denotes an oxygen atom, sulphur atom, or a group of the formula =N-X4 wherein X4 is as defined in the specification; Z1 denotes a nitrogen atom, or a group of the formula -CR3=; Z2 and Z3 each independently denote a nitrogen atom, a group of formula -CR1=, a carbonyl group, or a group of the formula =NR2; and the remaining substituents are as described in the specification. Compounds of the type disclosed are dipeptidyl peptidase-IV (DPPIV) inhibiting compounds useful in the treatment of diseases such as diabetes, obesity, hyperlipidemia, AIDS, osteoporosis, gastrointestinal disorder, angiogenesis, infertility, inflammatory disease, multiple sclerosis, allergic disease, or cancer, or as an immunoregulatory agent, hormone regulatory agent, or antirheumatic agent.
Patent NZ-541307-A (NZ)
Title: Substituted piperazine and piperidine heterocyclic compounds
Inventor: ZABLOCKI JEFF
IPC: C07D271/06
Filed: 2004-01-16
Abstract: Disclosed are compounds of formula I, wherein the substituents are as defined in the specification. The compounds are useful in the treatment of cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, ischemia, reperfusion injury, diabetes, myocardial infarction, and for increasing HDL levels in plasma while lowering LDL levels.
Patent NZ-544468-A (NZ)
Title: New benzamides as PPAR(gamma) modulators
Inventor: FERNANDEZ SERRAT ANNA
IPC: A61K31/381
Filed: 2004-06-11
Abstract: Disclosed are compounds of general formula (I), wherein the central benzene ring may be substituted in the meta- or para-position; A is an optionally substituted hydroxyl, alkoxyl, hydroxylamine, alkoxylamine or amine radical; W is an N- and C-linked biradical; and Z is a carbon radical. The compounds are PPAR(gamma) and PPAR(gamma)/PPAR(delta) modulators and, therefore, are useful for the prophylactic and/or curative treatment of conditions or diseases mediated by these receptors; such as conditions associated with metabolic disease including non-insulin-dependent diabetes mellitus (NIDDM), obesity, hypercholesterolaemia, lipid-mediated pathologies, cardiovascular diseases associated with metabolic syndrome, inflammation, rheumatoid arthritis, atherosclerosis, psoriasis, intestinal inflammatory disease, bone diseases including osteoporosis, cancer, skin wounds and cutaneous disorders associated with an anomalous differentiation of epidermic cells including the formation of keloids.
Patent NZ-550030-A (NZ)
Title: Perforated linear belt produce sizer
Inventor: FURNISS GREGORY WILLIAM GEORGE
Filed: 2006-09-22
Abstract: An apparatus for separating near-spherical items of varying size (9, 10, 11) into two classes, the classes being different in nominal diameter. The apparatus comprises: an endless linear belt (4) perforated with holes (5) of similar size such that items resting on or transported by the belt either fall through the holes under gravity, or are denied from doing so by the hole diameter being too small; pulley rollers (1, 2, 3) for the perforated belt to rotate around, being two (1, 2) of fixed position and one (3) beneath them capable of being moved in a short arc; a drive means to rotate the perforated belt and pulley rollers; a frame to support the perforated belt, pulleys and drive means; an endless auxiliary belt (8) which rotates inside the perforated belt to lift unselected items (9, 10) from the perforated belt; and a means (17) of enabling the items for sizing to rapidly assume a monolayer on the perforated belt if during input end deposition the items assume stacked cluster formation. A transverse conveyor (12) conveys selected items (11) which have fallen through holes in the perforated belt away from the main flow of items.
Patent NZ-551772-A (NZ)
Title: 4-phenyl-pyrimidine-2-carbonitrile derivatives
Inventor: CAI JIAQIANG
IPC: C07D239/28
Filed: 2005-06-09
Abstract: Disclosed is a compound of formula (I), wherein the substituents are as defined in the specification. The compounds are useful in the treatment of cathepsin K and cathepsin S related disorders such as atherosclerosis, bone diseases such as osteoporosis, inflammation and immune disorders such as rheumatoid arthritis and multiple sclerosis and chronic pain such as neuropathic pain.
Patent NZ-556436-A (NZ)
Title: Glycopegylated granulocyte colony stimulating factor
Inventor: DEFREES SHAWN
IPC: A61K38/19
Filed: 2006-01-10
Abstract: Disclosed is a granulocyte colony stimulating factor peptide comprising a glycosyl linking group attached to an amino acid residue of said peptide, said glycosyl linking group comprising a modified sialyl residue having the formula (I) wherein the substituents are disclosed within the specification. Also disclosed is the use of the peptide of formula (I) in the manufacture of a medicament for stimulating inflammatory leukocyte production or for treating infection. Also disclosed is a method of preparing the peptide of formula (I) using an enzyme that transfers PEG-sialic acid from a donor onto the Gal of the moiety.
Patent NZ-560803-A (NZ)
Title: 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
Inventor: PALLE VENKATA P
IPC: A61P11/06
Filed: 2006-02-21
Abstract: Disclosed is a carboxylic acid derivative of Formula Ic, or a racemate, enantiomer, diastereomer, or pharmaceutically acceptable salt thereof, wherein n is 1 to 5 and the other substituents are as defined in the specification. Also disclosed is the use of the compound for treating inflammatory diseases such as asthma, rheumatoid arthritis, COPD, rhinitis, osteoarthritis, psoriatic arthritis, psoriasis, pulmonary fibrosis, pulmonary inflammation, acute respiratory distress syndrome, perodontitis, multiple sclerosis, gingivitis, atherosclerosis, neointimal proliferation, which leads to restenosis and ischemic heart faliure, stroke, renal diseases or tumor metastasis. Also disclosed are processes for synthesising the above compound and for separating the compound into diastereomer pairs.
Patent NZ-567291-A (NZ)
Title: Formulations comprising jorumycin-, renieramycin-, safracin- or saframycin-related compounds for treating proliferative diseases
Inventor: CALVO SALVE PILAR
IPC: A61K9/00
Filed: 2006-10-30
Abstract: Disclosed are compositions comprising jorumycin, renieramycin, safracin or saframycin related compounds represented by general formula (I) and a disaccharide. Also disclosed is a method of making a vial containing lyophilised formulation of a compound of formula (I) and a disaccharide, comprising freeze-drying a bulk solution that comprises the compound and a disaccharide. Also disclosed is the use of the above mentioned solution in the manufacture of a medicament for the treatment of cancer, wherein the solution is formulated for administration by intravenous infusion.
Patent NZ-569485-A (NZ)
Title: Levodopa prodrug mesylate, compositions thereof, and uses thereof
Inventor: LI JIANHUA
IPC: A61K31/24
Filed: 2006-12-04
Abstract: The disclosure relates to (2R)-2-Phenylcarbonyloxypropyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate mesylate and crystalline form thereof, methods of making the same, pharmaceutical compositions thereof, and methods of using the same to treat diseases or disorders such as Parkinson's disease, schizophrenia, cognitive impairment disorders, restless legs syndrome, periodic limb movement disorders, tardive dyskinesia, Huntington's disease, hypertension, and excessive daytime sleepiness in a patient.
Patent NZ-569639-A (NZ)
Title: Method for joining two flexible grids and a fish pen manufactured therefrom
Inventor: HOFMANS GERRIT WILLEM KLASS
IPC: A01K61/00
Filed: 2007-02-06
Abstract: Pieces 4 of woven netting coated with a thermoplastic material are joined together at their edges by overlapping either the netting or an intermediate thermoplastic tape 5 and applying heat and pressure to the overlapped region to fuse the thermoplastic to form a joint between the pieces. The pieces may be joined in this way to form a fish pen net for breeding fish in open water.
Patent NZ-571990-A (NZ)
Title: Portable adaptor and software for use with a heads-up display unit
Inventor: MIMRAN EMILE
IPC: G02B27/14
Filed: 2006-03-16
Abstract: A heads-up display (HUD) adaptor (10A) in use in combination with an existing heads-up display (HUD) unit in a vehicle is disclosed. The HUD adaptor receives an electronic peripheral in order to display electronic data and information from the peripheral on a heads-up display screen of the existing HUD unit on a vehicle's front windshield. The HUD adaptor has a proximal end, a distal end and a cable therebetween and the proximal end includes a first adaptor plug; and the distal end including a second adaptor plug. The existing HUD unit includes the heads-up display screen on the front windshield of the vehicle and further includes a heads-up display control unit positioned within a control panel on a steering wheel or console of the vehicle for controlling each of the electronic peripherals. The existing HUD unit includes a USB panel member having a plurality of USB receiving ports for connecting one or more of the HUD adaptors thereto. The first adaptor plug (58) of the HUD adaptor is received within a receiving port (60) of the electronic peripheral. The second adaptor plug (62) of the HUD adaptor is received within one of the plurality of the USB receiving ports (32Aa) of the USB panel member (30) for electronically connecting the HUD adaptor to the HUD control unit; and the HUD control unit controls the electronic peripheral to display electronic data or information therefrom on the screen of the HUD unit on the vehicle's windshield.